pubmed-article:1458609 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1458609 | lifeskim:mentions | umls-concept:C0005889 | lld:lifeskim |
pubmed-article:1458609 | lifeskim:mentions | umls-concept:C0302908 | lld:lifeskim |
pubmed-article:1458609 | lifeskim:mentions | umls-concept:C0001128 | lld:lifeskim |
pubmed-article:1458609 | lifeskim:mentions | umls-concept:C0268165 | lld:lifeskim |
pubmed-article:1458609 | lifeskim:mentions | umls-concept:C0185125 | lld:lifeskim |
pubmed-article:1458609 | lifeskim:mentions | umls-concept:C1510438 | lld:lifeskim |
pubmed-article:1458609 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:1458609 | pubmed:dateCreated | 1993-1-14 | lld:pubmed |
pubmed-article:1458609 | pubmed:abstractText | We describe a liquid chromatographic technique to determine L-glycerate in body fluids. The method is based on the derivatisation of the L-glycerate by incubation with lactate dehydrogenase and nicotinamide-adenine dinucleotide in the presence of phenylhydrazine. Oxidation of L-glycerate forms beta-hydroxypyruvate which is converted in turn into the related phenylhydrazone. The UV-absorbing derivative is determined using reversed-phase high performance liquid chromatography. The sensitivity was 5 mumol/l and 50 microliters of sample were required. The imprecision relative standard deviation was 4.5% and the recovery was 96.5 +/- 6.8% for L-glycerate in plasma. L-Glycerate concentrations in urine and plasma were less than 5 mumol/l in both normal individuals and patients with glycolic aciduria. In a patient with systemic oxalosis and normal plasma glycolate, plasma L-glyceric acid was 887 mumol/l. | lld:pubmed |
pubmed-article:1458609 | pubmed:language | eng | lld:pubmed |
pubmed-article:1458609 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1458609 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1458609 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1458609 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1458609 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1458609 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1458609 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1458609 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1458609 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1458609 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1458609 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1458609 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1458609 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1458609 | pubmed:month | Oct | lld:pubmed |
pubmed-article:1458609 | pubmed:issn | 0009-8981 | lld:pubmed |
pubmed-article:1458609 | pubmed:author | pubmed-author:LinardCC | lld:pubmed |
pubmed-article:1458609 | pubmed:author | pubmed-author:MarangellaMM | lld:pubmed |
pubmed-article:1458609 | pubmed:author | pubmed-author:PetraruloMM | lld:pubmed |
pubmed-article:1458609 | pubmed:author | pubmed-author:CossedduDD | lld:pubmed |
pubmed-article:1458609 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1458609 | pubmed:day | 30 | lld:pubmed |
pubmed-article:1458609 | pubmed:volume | 211 | lld:pubmed |
pubmed-article:1458609 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1458609 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1458609 | pubmed:pagination | 143-53 | lld:pubmed |
pubmed-article:1458609 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:1458609 | pubmed:meshHeading | pubmed-meshheading:1458609-... | lld:pubmed |
pubmed-article:1458609 | pubmed:meshHeading | pubmed-meshheading:1458609-... | lld:pubmed |
pubmed-article:1458609 | pubmed:meshHeading | pubmed-meshheading:1458609-... | lld:pubmed |
pubmed-article:1458609 | pubmed:meshHeading | pubmed-meshheading:1458609-... | lld:pubmed |
pubmed-article:1458609 | pubmed:meshHeading | pubmed-meshheading:1458609-... | lld:pubmed |
pubmed-article:1458609 | pubmed:meshHeading | pubmed-meshheading:1458609-... | lld:pubmed |
pubmed-article:1458609 | pubmed:meshHeading | pubmed-meshheading:1458609-... | lld:pubmed |
pubmed-article:1458609 | pubmed:meshHeading | pubmed-meshheading:1458609-... | lld:pubmed |
pubmed-article:1458609 | pubmed:meshHeading | pubmed-meshheading:1458609-... | lld:pubmed |
pubmed-article:1458609 | pubmed:meshHeading | pubmed-meshheading:1458609-... | lld:pubmed |
pubmed-article:1458609 | pubmed:meshHeading | pubmed-meshheading:1458609-... | lld:pubmed |
pubmed-article:1458609 | pubmed:meshHeading | pubmed-meshheading:1458609-... | lld:pubmed |
pubmed-article:1458609 | pubmed:meshHeading | pubmed-meshheading:1458609-... | lld:pubmed |
pubmed-article:1458609 | pubmed:year | 1992 | lld:pubmed |
pubmed-article:1458609 | pubmed:articleTitle | High-performance liquid chromatographic assay for L-glyceric acid in body fluids. Application in primary hyperoxaluria type 2. | lld:pubmed |
pubmed-article:1458609 | pubmed:affiliation | Renal Stone Laboratory, Ospedale Mauriziano Umberto I, Turin, Italy. | lld:pubmed |
pubmed-article:1458609 | pubmed:publicationType | Journal Article | lld:pubmed |